Recce scores US$2M deal from US Department of Defense for burn wound infections gel
Recce Pharmaceuticals Ltd has been funded to the tune of US$2M by the US Department of Defense to develop its R327G gel.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No Corporate Spotlight currently available.